It’s scary to think that we may have been using a surrogate — BMI — that may not have been all that accurate over the years," ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...

A unique business structure gives LifeMD access to the growing GLP-1 marketplace that can help boost the heavily shorted stock price. Read an analysis of LFMD here.